Multi-Dose Nasal Delivery

Spravato Nasal Spray

Janssen

Background

Janssen selected an Aptar technology as the preferred drug delivery device for their Esketamine product, used to treat severe depression. The project team identified a need to customise the baseline device and saw Shore as the perfect partner to lead this aspect of the program.

Showcasing the strengths of our combined design and engineering team, this project saw us successfully develop a version of the platform drug delivery device to meet the user group’s needs and our customer’s commercial launch objectives. Included in our scope was the development of commercial Instructions for Use (IFU) and secondary packaging to complement the improved device design.

Our innovative solution enhances the device’s usability while ensuring no impact on the core functional elements of the platform technology.

Value Delivered

Platform device customised to customer and patient needs
Improved reliability and performance in users hands
Enhanced user interface
Complimentary packaging and IFU solutions
Valuable intellectual property generated for Janssen

Project Scope

Product Architecture, Usability Engineering, Mechanical Engineering, Design for Manufacture (DFM), Prototype & Evaluation, New Product Integration, Design Transfer

Project Scope

Product Architecture
Usability Engineering
Mechanical Engineering
Design for Manufacture (DFM)
Prototype & Evaluation
New Product Integration
Design Transfer

“Thank you for your critical contribution to this program. We could not have done this without you. Shore has done so much for the Esketamine program: all the design and engineering support starting way back in 2012, and the amazing commercial trainer. You are an integral part of the care, dedication, and teamwork that made this possible.”

Engineering Director, Janssen R&D

Enjoyed this nasal drug delivery case study?